GMS Ventures & Investments 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-29 4:43 pm Purchase |
2022-12-28 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS Ventures & Investments | 3,563,876 27.900% |
711,521 (+24.95%) |
Filing |
| 2022-07-07 5:20 pm Purchase |
2022-07-05 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS Ventures & Investments | 2,852,355 25.100% |
2,852,355 (New Position) |
Filing |